Screener
Gyre Therapeutics, Inc. GYRE Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s net debt / EBITDA?
- Gyre Therapeutics, Inc. (GYRE) reported net debt / EBITDA of -5× in Q4 2025.
- How has Gyre Therapeutics, Inc.'s net debt / EBITDA changed year-over-year?
- Gyre Therapeutics, Inc.'s net debt / EBITDA decreased by 775.5% year-over-year, from -0.6× to -5×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Gyre Therapeutics, Inc.'s net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude